Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
P311 induces a TGF-β1–independent, nonfibrogenic myofibroblast phenotype
Desi Pan, … , Gregory A. Taylor, Lucia Schuger
Desi Pan, … , Gregory A. Taylor, Lucia Schuger
Published November 1, 2002
Citation Information: J Clin Invest. 2002;110(9):1349-1358. https://doi.org/10.1172/JCI15614.
View: Text | PDF
Article Cell biology

P311 induces a TGF-β1–independent, nonfibrogenic myofibroblast phenotype

  • Text
  • PDF
Abstract

Research Article

Authors

Desi Pan, Xiaoning Zhe, Sandhya Jakkaraju, Gregory A. Taylor, Lucia Schuger

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
P311 is expressed in human visceral and vascular SM cells and myofibrobl...
P311 is expressed in human visceral and vascular SM cells and myofibroblasts. All the sections have been double immunostained for P311 and SM α-actin, the latter to identify SM and myofibroblasts. (a) P311 is present in both visceral (intestine) and vascular SM (first and second panels down, respectively). P311 is not synthesized by fibroblasts (third panels), but is produced by myofibroblasts (fourth panels). (b) Immunohistochemical studies performed at an early stage of wound repair demonstrate P311 in most of the activated fibroblasts, also referred to as premyofibroblasts (SM α-actin–negative myofibroblast precursors, arrow in upper left photo). In more advanced stages of wound healing (two middle panels), P311 is detected in myofibroblasts (activated, SM α-actin–positive cells). Arrowhead in the second left photo points to a regular fibroblast present in the same field. Notice its smaller size, lack of discernible nucleoli, and negativity for P311. Once myofibroblasts disappear and the wound contains only regular fibroblasts, P311 is no longer detected (lowest panels).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts